tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
VYNE
VYNE Therapeutics
RESEARCH TOOLSreports

VYNE Therapeutics (VYNE) Balance Sheet

1,902 Followers

VYNE Therapeutics Balance Sheet

VYNE Therapeutics's total assets for Q4 2025 were $30.16M, a decrease of -16.53% from the previous quarter. VYNE total liabilities were $2.40M for the fiscal quarter, a -40.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 30.16M$ 66.91M$ 97.69M$ 40.76M$ 67.05M
Total Liabilities
$ 2.40M$ 14.82M$ 8.95M$ 9.56M$ 18.41M
Total Equity Gross Minority
$ 27.77M$ 52.09M$ 88.73M$ 31.20M$ 48.64M
Other Metrics
Currency in USD

VYNE Therapeutics Debt to Assets